N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-ORTHO-HYDROXYPHENYL-L-PARA-TYROSINAMIDE
Compound with spectra: 1 NMR
![N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-ORTHO-HYDROXYPHENYL-L-PARA-TYROSINAMIDE](/api/compound/A1a6H7Uu6YR.png?ph=true&h=300&w=458 "N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-ORTHO-HYDROXYPHENYL-L-PARA-TYROSINAMIDE")
| SpectraBase Compound ID | A1a6H7Uu6YR |
|---|---|
| InChI | InChI=1S/C35H44Cl2N4O5/c36-20-23-41(24-21-37)28-16-12-26(13-17-28)7-6-11-33(44)38-22-5-1-2-10-34(45)39-31(25-27-14-18-29(42)19-15-27)35(46)40-30-8-3-4-9-32(30)43/h3-4,8-9,12-19,31,42-43H,1-2,5-7,10-11,20-25H2,(H,38,44)(H,39,45)(H,40,46)/t31-/m1/s1 |
| InChIKey | JKTRZNSDAKKAQB-WJOKGBTCSA-N |
| Mol Weight | 671.7 g/mol |
| Molecular Formula | C35H44Cl2N4O5 |
| Exact Mass | 670.268876 g/mol |
| Enantiomer InChIKey | JKTRZNSDAKKAQB-HKBQPEDESA-N |
| Racemate InChIKey | JKTRZNSDAKKAQB-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
N-[1-benzyl-2-oxo-2-(3,4,5-trimethoxyanilino)ethyl]cyclohexanecarboxamide
N-(2-keto-3,4-dihydro-1H-quinolin-3-yl)benzamide
ethyl 3-({2-[(cyclohexylcarbonyl)amino]-3-phenylpropanoyl}amino)benzoate
alpha-(o-nitrobenzamido)hydrocinnamanilide
2-[[2-[[3-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-hydroxy-4-keto-butanoyl]amino]-3-phenyl-propanoyl]amino]-4-methyl-valeric acid
3,4-DIHYDRO-3-ISOBUTYL-1H-1,4-BENZODIAZEPINE-2,5-DIONE
N-Hydrxysuccinyl-L-phenylalanyl-L-alanyl [(2,4,6-Trimethylbenzoyl)oxy]methyl ketone
2-Oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-triene-5,8-dione, 4-amino-7-benzyl-3-isopropyl-
Na-(3,5-dinitrobenzoyl)tyrosine N'-[4-(dimethylamino)benzylidene]hydrazide
1,2,3,4,5-Pentahydro-3-(2-hydroxyethyl)-[1,4]benzodiazepine-2,5-dione
| Title | Journal or Book | Year |
|---|---|---|
| Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines | Steroids | 2012 |